Coordinate the response and keep each commitment after it goes out
- Each claim checked before writing
- The full extent, paper logbooks included
- Dates their owners have accepted
A Form 483 response that checks each sentence of an observation against your records, traces how far it reaches across lots, batches and clients, and has a challenger read the draft as FDA's reviewer would before named people sign it.
See one observation answered screen by screen ↓A response that arrives within fifteen business days of the form gets a detailed review before FDA decides whether to issue a warning letter. At a drug substance contract manufacturer, one observation can reach shared reactors, a shared solvent recovery unit, one QC lab and several clients' products. Yet the response is usually written in a word processor from system exports, by the people who sat in the inspection, and its extent is the cited examples plus whatever someone remembers.
FDA's published warning letters call responses inadequate when they fix only the cited examples, skip the retrospective review, assess no material already used or shipped, name no interim control or attach no evidence. Commitment dates go into the letter before their owners have seen them, each client's part is pieced together afterward, and the commitments end up in a spreadsheet until the next inspection finds the same gap.
Built forQA compliance leadsHeads of qualityPlant QA headsSite headsCAPA owners
An answer that covers only the examples on the form leaves other lots, batches and clients for FDA to find.
Pieced together from exports
Built-in controls
Investigators and clients see a site that answers the whole extent and keeps the dates it gave.
The response coordinator, the plant QA head, CAPA owners and the client quality liaison use them on one drug substance site's observation about recovered solvents, three business days before the response is due.
demoSample data throughout: the CDMO, its clients, the people, lots, batches, records and dates.
One person runs the response; the quality unit signs it; the people who will do the work decide when.
Coordinate the response and keep each commitment after it goes out
Sign each observation's section and each client notice
Sign the letter and approve the rules the team learns
Accept or move commitment dates and attach the proof
Around the letter: the inspection history, the exhibits, what the team has learned, who did what, and the settings.
demoSample data, from the working solution.
Each agent hands its work to the next by name, and each decision ends with a person.
Splits each observation into the claims it makes, sentence by sentence, in the investigator's own words.
Opens the record each claim names and marks it matches, needs context or not found.
Follows lots through ERP issues and scanned logbooks to every batch, product and client, and where each batch is now.
Drafts each section in reviewer order, numbers the exhibits and writes commitments with accepted dates.
Reads the draft as FDA's response reviewer and checks the team's own sentences against their exhibits.
Drafts each client's part under the clause of that client's agreement, limited to its products.
Watches each commitment after the response goes out, asks owners for evidence and drafts update letters.
A Form 483 response is the site's written answer to the observations an FDA investigator issues at the close of an inspection. Here agents check each sentence of an observation against the records, trace how far it reaches, and draft the answer in the order FDA's reviewer reads it; named people sign it.
FDA gives a detailed review to a response it receives within fifteen business days of the form, before it decides whether to issue a warning letter. The clock here counts business days from the form's date with federal holidays excluded, and an internal target asks for signed sections two business days earlier.
Past the cited examples. FDA's draft guidance on responding to Form 483 observations asks a site to check whether a deficiency affects other drugs, processes, facilities and contract organizations. Here the extent tracer follows each affected lot to every batch made with it and to where that batch is now.
No. Each client gets a notice with only its own products and batches, under the clause of its own quality agreement, prepared by the client quality liaison and signed by the plant QA head.
The plant QA head signs each observation's section after opening its sampled exhibits, the coordinator signs as preparer, and the letter carries the head of quality's and the plant head's signatures as executive management. No signer checks their own work.
It tracks one the same way: the deficiencies with their critical, major and other grading, the commitments made and the proof behind each. The sentence-by-sentence answer is for the Form 483.
The commitment keeper watches each commitment, asks owners for evidence and drafts update letters on the promised dates. A commitment closes only when a second person has opened its proof.
Leadership decides on what an inspector would meet first, and each review opens with whether last quarter's actions were done.
1-min demoClient Batch Release PackagePackages reach the client already checked the way the client's own reviewer checks them, so its release is not held up by send-backs.
1-min demoDeviation Reporting & ClassificationEvery report heard in the operator's own words, contained at once, classified by QA the same day.
1-min demoSend one closed observation with the records behind it, and we will show its claims checked and its extent traced.